跳至主要内容
临床试验/CTRI/2011/09/002003
CTRI/2011/09/002003招募中2/3 期

A CLINICAL STUDY TO EVALUATE THE ROLE OF DOSHIK PREDOMINANCE IN THE MANAGEMENT OF AMLAPITTA

IPGT and RA1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年8月17日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
90
试验地点
1
主要终点
Agni bala ( power of digestion)

研究概览

简要总结

This trial is a randomized open clinical trial for assessing the Doshic predominence in Amlapitta wsr to the efficacy of Vasa Khanda Kushmandaka Avaleha and Shunti Khanda in granules form, each 5 g BD for 30 days

研究设计

研究类型
Interventional
分配方式
Other
盲法
Not Applicable

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Presence of Pratyatmaka Laksanas of Amlapitta Chronicity- more than 3 months duration.

排除标准

  • Chronicity of the disease less than 3 months Patients with Peptic Ulcer Duodenal Ulcer CA Stomach Cardiac disorders.
  • Taking medicines for any other diseases like Hypertension Diabetes Mellitus Ischemic Heart Diseases Chronic Renal Failure.

结局指标

主要结局

Agni bala ( power of digestion)

时间窗: Assessment will be done on every week based on scoring of cardinal symptoms

Subjective and objective signs and symptoms

时间窗: Assessment will be done on every week based on scoring of cardinal symptoms

Roga bala ( severity of disease)

时间窗: Assessment will be done on every week based on scoring of cardinal symptoms

Deha bala ( strength of the body) and Chetas bala ( mental strength)

时间窗: Assessment will be done on every week based on scoring of cardinal symptoms

Brief Psychiatric rating scale

时间窗: Assessment will be done on every week based on scoring of cardinal symptoms

次要结局

  • exacerbations in signs and symptoms(1 week)

研究者

发起方
IPGT and RA
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验